Skip to content

CareDx CDNA Finished goods

Finished goods at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
Danaher logo
DanaherDHR
Abbott logo
AbbottABT
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's finished goods?
CareDx (CDNA) reported finished goods of $11.17M in Q1 2026.
How has CareDx's finished goods changed year-over-year?
CareDx's finished goods increased by 152.8% year-over-year, from $4.42M to $11.17M.
What is the long-term trend for CareDx's finished goods?
Over 4 years (2021 to 2025), CareDx's finished goods has grown at a 25.8% compound annual growth rate (CAGR), from $3.91M to $9.8M.